[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]
Fırat University Medical Journal of Health Sciences
2023, Cilt 37, Sayı 3, Sayfa(lar) 193-199
[ Turkish ] [ Tam Metin ] [ PDF ]
The Effect of Quercetin, Alpha Lipoic Acid and Thiazolidine Treatment on Metabolic Syndrome and Resistin Level in Rat Model
Arzu PARMAKSIZ1, Burkay YAKAR2, Erhan ÖNALAN3, Emir DÖNDER3, Mehmet Ferit GÜRSU1
1Fırat University, Faculty of Medicine, Department of Medical Biochemistry, Elazig, TURKIYE
2Fırat University, Faculty of Medicine, Department of Family Medicine, Elazig, TURKIYE
3Fırat University, Faculty of Medicine, Department of Internal Medicine, Elazig, TURKIYE
Keywords: Metabolic syndrome, resistin, quercetin, alpha lipoic acid, tiazolidindion

Objective: The metabolic syndrome (MetS) is a common and important public health problem. High resistin levels may be associated with MetS, and practices to reduce resistin levels may be effective in the treatment of MetS. The current study was aimed to compare the effects of different treatment methods applied in metabolic syndrome on resistin and biochemical parameters.

Materials and Methods: A total of 60 rats weighing 250±20 grams were divided into 6 groups. Group 1 (n=10, control group), Group 2 (n=10, MetS group), Group 3 (n=10, MetS+ quercetin treatment), Group 4 (n=10, MetS+ Alpha lipoic acid (ALA) treatment), Group 5 (n=10, MetS+ quercetin + ALA treatment), Group 6 (n=10, MetS+ Tiazolidindion (TZD) treatment). The experiment was terminated at the end of 55 days and blood samples were taken from all rats.

Results: Serum resistin levels increased significantly in rats with MetS (p<0.001) and decreased in quercetin (p<0.001), ALA (p<0.001) quercetin + ALA (p<0.001) and TZD (p<0.001) groups. Serum glucose, insulin and HOMA-IR values were lower in treated groups than in MetS group. Quercetin and quercetin+ALA treatments had a much more positive effect on lipid and uric acid levels compared to the treatment with TZD.

Conclusions: Resistin level increased in rats with metabolic syndrome. All of the different treatment methods applied were found to be associated with a decrease in resistin levels and improvement in biochemical parameters. We believe that reduction in resistin levels and success in the management of MetS can be achieved with the treatment agents used in our study.


[ Turkish ] [ Tam Metin ] [ PDF ]
[ Ana Sayfa | Editörler | Danışma Kurulu | Dergi Hakkında | İçindekiler | Arşiv | Yayın Arama | Yazarlara Bilgi | E-Posta ]